| Literature DB >> 12873500 |
Stephen J Davies1, Andrew P Ayscough, R Paul Beckett, John M Clements, Sheila Doel, Lisa M Pratt, Zoë M Spavold, S Wayne Thomas, Mark Whittaker.
Abstract
Structural modifications to the peptide deformylase inhibitor BB-3497 are described. In this paper, we describe the initial SAR around this lead for modifications to both the P2' and P3' side chains. Enzyme inhibition and antibacterial activity data revealed that a variety of substituents are tolerated at the P2' and P3' positions of the inhibitor backbone. The data from this study highlights the potential for modification at the P2' and P3' positions to optimise the physicochemical properties.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12873500 DOI: 10.1016/s0960-894x(03)00533-x
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823